Bone and Mineral Metabolism Disorders
SAN DIEGO — At ASN Kidney Week 2018, Annamaria T. Kausz, MD, MS, discussed two phase III trials that evaluated the safety and efficacy of ALLN-177 in patients with enteric hyperoxaluria.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.